Clinical Trial Update: Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study assessing the effect of beta-blocker or aldosterone antagonist therapy in patients with liver cirrhosis and portal hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Aldosterone antagonist therapy (aldosterone antagonist)
• beta-blocker therapy

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 4 | Status: UNKNOWN